Kala Bio (KALA) Other Non-Current Liabilities (2016 - 2025)
Kala Bio (KALA) recorded Other Non-Current Liabilities of $3.23 million in Q2 2025, down 23.8% from $4.24 million a year earlier but up 3.7% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Other Non-Current Liabilities (2016 - 2025) Analysis & Trends
At the end of FY2024, Kala Bio reported Other Non-Current Liabilities of $4.66 million, up 13.4% from FY2023.
- Annual Other Non-Current Liabilities has a three-year compound annual growth rate of -1.3% (FY2021 to FY2024).
- Across earlier years, Other Non-Current Liabilities came in at $4.11 million in FY2023 (-2.7%), $4.22 million in FY2022 (-12.7%) and $4.84 million in FY2021.
- Quarterly Other Non-Current Liabilities has ranged from $3.12 million in Q1 2025 to $5.59 million in Q2 2023 over the past five years.
- On a year-over-year basis, Other Non-Current Liabilities rose in three of the last eight quarters, with an average decline of 7.5%.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 45.6% in Q2 2023, against a decline of 27.0% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.12 million (Q1 2025), $4.66 million (Q4 2024) and $4.66 million (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kala Bio | 6.57 Mn | 6.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 3.23 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 4.66 Mn |
| Sep 30, 2024 | 4.66 Mn |
| Jun 30, 2024 | 4.24 Mn |
| Mar 31, 2024 | 4.27 Mn |
| Dec 31, 2023 | 4.11 Mn |
| Sep 30, 2023 | 3.84 Mn |
| Jun 30, 2023 | 5.59 Mn |
| Mar 31, 2023 | 5.23 Mn |
| Dec 31, 2022 | 4.22 Mn |
| Sep 30, 2022 | 3.78 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | 4.00 Mn |
| Dec 31, 2021 | 4.84 Mn |
| Dec 31, 2017 | 8,000.00 |
| Sep 30, 2017 | 15,000.00 |
| Jun 30, 2017 | 2.26 Mn |
| Dec 31, 2016 | 1.04 Mn |
API Access
Kala Bio Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();